???global.info.a_carregar???
Helena Cortez-Pinto.
Identification

Personal identification

Full name
Helena Cortez-Pinto

Citation names

  • Cortez-Pinto, Helena
  • Pinto, Helena C

Author identifiers

Ciência ID
A01C-0511-C986
ORCID iD
0000-0002-8537-8744
Education
Degree Classification
2000
Concluded
Medicina (Doutoramento)
Major in Medicina
Universidade de Lisboa Faculdade de Medicina, Portugal
20
1981
Concluded
Medicina (Licenciatura)
Universidade de Lisboa Faculdade de Medicina, Portugal
17
Affiliation

Teaching in Higher Education

Category
Host institution
Employer
2016/12 - Current Full Professor (University Teacher) Universidade de Lisboa Faculdade de Medicina, Portugal

Other Careers

Category
Host institution
Employer
2011 - Current Assistente graduado sénior (Médica) Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
Projects

Contract

Designation Funders
2017 - Current Litmus - Liver Investigation: Testing Marker Utility in Steatohepatitis
777377
Principal investigator
Universidade de Lisboa Faculdade de Medicina, Portugal
Ongoing
2024/01/01 - 2028/01/01 GRIPonMASH
Principal investigator
Universidade de Lisboa Faculdade de Medicina, Portugal
Ongoing
2022/01/01 - 2024/12/31 TRANSLATING RIPK3 SIGNALLING INTO APPLICATION IN METABOLIC LIVER DISEASE
PTDC/MED-FAR/3492/2021
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2018/06/01 - 2022/02/28 Non-alcoholic Fatty Liver Disease: Emerging Biomarkers, Targets and Therapies
PTDC/MED-FAR/29097/2017
Universidade de Lisboa Faculdade de Farmácia, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2016/09/01 - 2019/08/31 Técnicas de Imagem Molecular da Fibrose Hepática
HMSP-ICT/0012/2013
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal

Athinoula A Martinos Center for Biomedical Imaging, United States

Centro Hospitalar e Universitário de Coimbra EPE, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2016/07/01 - 2019/06/30 Novas Moléculas para Tratar Fígado Gordo não Alcoólico e Progressão para Cancro
PTDC/BIM-MEC/0895/2014
Centro Hospitalar de Lisboa Central EPE, Portugal

Centro Hospitalar Universitário Lisboa Norte EPE, Portugal

Harvard Medical School Department of Cell Biology, United States
Fundação para a Ciência e a Tecnologia
Concluded
2015 - 2019 Carbalive: clinical evaluation of nanoporous carbon adsorbent with tailored porosity (Yaq-0 liver disease 01) as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty disease
634579
Principal investigator
Universidade de Lisboa Faculdade de Medicina, Portugal
Concluded
2013/06/01 - 2016/11/30 TRATAR DOENÇAS HEPÁTICAS TENDO COMO ALVO A NECROPTOSE DOS HEPATÓCITOS
HMSP-ICT/0018/2011
Fundação Calouste Gulbenkian, Portugal

Harvard Medical School Department of Cell Biology, United States

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2013/07/01 - 2015/12/31 Com o miR-21 e os receptores ativados pelos ácidos biliares em mira na patogénese do fígado gordo não alcoólico: duas balas para um homicídio?
PTDC/BIM-MEC/0873/2012
University of Minnesota Department of Medicine, United States

The University of Texas Southwestern Medical Center, United States

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2012/03/01 - 2015/06/30 NecroPT - Modular da Necroptose no Tratamento de Doenças Hepáticas
PTDC/SAU-ORG/119842/2010
Universidade de Lisboa Faculdade de Farmácia, Portugal

Harvard Medical School Department of Cell Biology, United States

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2011/01/03 - 2014/07/02 Modulação do microRNA-34, um Elo Potencial entre a Apoptose e a Patogénese do Fígado Gordo Não Alcoólico
PTDC/SAU-ORG/111930/2009
Universidade de Lisboa Faculdade de Farmácia, Portugal

University of Minnesota Department of Genetics Cell Biology and Development, United States

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2009 - 2013 Prevalência e gravidade do fígado gordo na obesidade mórbida: correlações e mecanismos relacionados com o papel da gordura ectópica na resistência à insulina
PTDC/SAU-OSM/100878/2008
PTDC/SAU-OSM/100878/2008
Other
Universidade de Lisboa Faculdade de Medicina, Portugal

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal

Universidade de Lisboa Faculdade de Farmácia, Portugal
N/A

Fundação para a Ciência e a Tecnologia
Concluded
2008/06/16 - 2012/02/14 Nutracêuticos: que papel na prevenção na doença crónica? - contributo para a fundamentação de uma nova opção terapêutica -
PTDC/SAU-OSM/66323/2006
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Fundação Calouste Gulbenkian, Portugal

Hospital Pulido Valente, Portugal

Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded

Other

Designation Funders
2021/10/01 - Current Clinical trial: The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis
Trial ID NN9931-4553
Principal investigator
Novo Nordisk A/S, Latvia
Novo Nordisk A/S
Ongoing
2020/10/01 - Current Clinical trial 1404-P01-P02-P03
Principal investigator
Boehringer Ingelheim RCV GmbH und Co KG, Austria
Boehringer Ingelheim RCV GmbH und Co KG
Ongoing
2016 - Current Ensaio clínico: Regenerate NASH Protocol 747-303
747-303
Other
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2016 - Current Ensaio clínico RESOLVE-IT
Principal investigator
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
Ongoing
2012 - 2015 Estimativa da prevalência de esteatose hepática e das hepatites víricas na população portuguesa
0
Principal investigator
Instituto de Medicina Molecular João Lobo Antunes, Portugal
Concluded
Outputs

Publications

Book chapter
  1. Cortez-Pinto, H.. "Diagnostic Algorithm for the Identification of NAFLD in Primary Care". 225-234. 2020.
  2. Machado, M.V.; Ferreira, D.M.S.; Castro, R.E.; Silvestre, A.R.; Evangelista, T.; Coutinho, J.; Carepa, F.; et al. "Liver and muscle in morbid obesity: The interplay of fatty liver and insulin resistance". 145-173. 2016.
  3. Cortez-Pinto, Helena; Machado, M.V. "Evaluating the NAFLD patient: putting in perspective non-invasive and invasive methods". In Therapy in Liver Diseases. 2013.
  4. Cortez-Pinto, Helena. "Cirrose hepática". In Aparelho Digestivo. Clínica e Cirurgia. 2012.
  5. Cortez-Pinto, Helena. "Genética e Fígado gordo não alcoólico. Esteato-hepatite e suas correlações.". In Doença Hepática Gordurosa não alcoólica. 2011.
  6. Cortez-Pinto, Helena. "Resistência à insulina e esteatose na hepatite crónica C.". In Terapêutica de formas particulares de hepatites virais. 2009.
  7. Cortez-Pinto, Helena. "Epidemiology and risk factors of NASH". In Nonalcoholic steatohepatitis. In International Hepatology Updates. 2007.
  8. Cortez-Pinto, Helena. "Fígado gordo e NASH". In Tratado de Hepatologia.. 2006.
  9. Cortez-Pinto, Helena. "Esteatohepatite não alcoólica". In Diagnóstico em Hepatologia. 2004.
  10. Cortez-Pinto, Helena. "Tratamento da esteatohepatite alcoólica e não alcoólica". In Terapêutica Hepatológica. 2003.
  11. Cortez-Pinto, Helena. "Oxidative stress in alcoholic and non-alcoholic liver disease". In Steatohepatitis (NASH and ASH). 2002.
Conference paper
  1. Carvalhana, Sofia; Leitão, Jorge; Alves, Catarina; Bourbon, Mafalda; Cortez-Pinto, Helena. "Good correlation between plasma cytokeratin-18 and controlled attenuation parameter (CAP) in healthy population". 2014.
  2. Carvalhana, Sofia; Pinto, Rui; Leitão, Jorge; Silva, Ana Paula; Alves, Catarina; Bourbon, Mafalda; Carvalho, Armando; Cortez-Pinto, Helena. "HCV and HBV prevalence in the population: Large disparity between Hepatitis C in the general population, comparing with high risk groups". 2014.
  3. Carvalhana, Sofia; Leitão, Jorge; Alves, Catarina; Bourbon, Mafalda; Cortez-Pinto, Helena. "“Normal” controlled attenuation parameter (CAP) values: a population-based study of healthy subjects". 2014.
  4. Carvalhana, Sofia; Leitão, Jorge; Silva, Ana Paula; Alves, Catarina; Bourbon, Mafalda; Carvalho, Armando; Cortez-Pinto, Helena. "Prevalence of hepatic steatosis in the general Portuguese population: using fatty liver index (FLI) and ultrasound". 2014.
  5. Carvalhana, Sofia; Pinto, Rui; Leitão, Jorge; Silva, Ana Paula; Alves, Catarina; Bourbon, Mafalda; Carvalho, Armando; Cortez-Pinto, Helena. "Hepatitis B serologic markers after 14 years of universal new-born vaccination". 2014.
  6. Alexandrino, P.; Martins Alves, M.; Oliveira, A.G.; Esteves, A.V.; Fidalgo, P.; Cortez Pinto, H.; Ermelinda Camilo, M.; Pinto Correia, J.. "Gastrointestinal hemorrhage due to rupture of esophageal varices,HEMORRAGIA DIGESTIVA ALTA POR ROTURA DE VARIZES ESOFAGICAS". 1991.
Conference poster
  1. Mafalda João; Sofia Carvalhana; Miguel Moura; Luís Carlos Freitas; Andrea Silva; Pedro Figueiredo; Rodrigo Liberal; et al. Corresponding author: Helena Cortez-Pinto. "FATORES PREDITORES DE AUSÊNCIA DE RESPOSTA A CORTICOTERAPIA NA HEPATITE AUTOIMUNE AGUDA GRAVE". Paper presented in Congresso Português de Hepatologia - 2ª Reunião Anual da APEF, 2021.
  2. Joshua Card Gowers; Daniel Ohrenstein; Laura Webber; Hannah Graff; Juan Vesga; Maria Buti; Cortez-Pinto, Helena; et al. "Projecting the prevalence of obesity and alcohol-related non-communicable diseases in France from 2020 to 2030 using multi-risk microsimulation methods: preliminary results". Paper presented in ECO Online 2021 - 28th European Congress on Obesity, 2021.
  3. Leitao, Jorge; Carvalhana, S.; Cochicho, Joana; Silva, AP; Velasco, Francisco; Medeiros, Isabel; Alves, Ana Catarina; et al. Corresponding author: Leitao, Jorge. "Prevalence of alcoholic steatosis in the general adult Portuguese population". Paper presented in The International Liver Congress, Paris, 2018, 2018.
  4. Guerreiro, Catarina Sousa; Vasques, J.; Sousa, J.; Cortez-Pinto, Helena. "SGA ou RFHGA para avaliar o estado nutricional em doentes com cirrose hepática?". Paper presented in Semana Digestiva de 2018, 2018.
  5. Leitao, Jorge; Cochicho, Joana; Carvalhana, S.; Silva, Ana Paula; Velasco F; Medeiros I; Alves AC; et al. Corresponding author: Leitao, Jorge. "Hepatic steatosis in an adult population: stronger correlation with the presence of obesity and insulin resistance than with the dietary pattern. Results from a cross-sectional study". Paper presented in The International Liver Congress, Amsterdam, 2017, 2017.
  6. Leitao, Jorge; Cochicho, Joana; Carvalhana, Sofia; Silva, Ana Paula; Velasco, F.; Medeiros, Isabel; Alves, AC; et al. Corresponding author: Leitao, Jorge. "Vitamin D serum levels are only marginally lower in hepatic steatosis and do not correlate with Vitamin D dietary ingestion". Paper presented in The International Liver Congress, Amsterdam, 2017, 2017.
  7. Machado, Mariana; Policarpo, S.; Barreira, S; Carvalhana, S.; Leitao, Jorge; Silva, AP; Velasco, F.; et al. "How often do we misclassify alcoholic as nonalcoholic fatty liver disease due to subjectivity in assessing alcohol consumption?". Paper presented in The International Liver Congress, Amsterdam, 2017, 2017.
Journal article
  1. Feng, Gong; Targher, Giovanni; Byrne, Christopher D.; Yilmaz, Yusuf; Wai-Sun Wong, Vincent; Adithya Lesmana, Cosmas Rinaldi; Adams, Leon A.; et al. "Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021". JHEP Reports 7 3 (2025): 101271. https://doi.org/10.1016/j.jhepr.2024.101271.
    10.1016/j.jhepr.2024.101271
  2. Samuel Raimundo Fernandes; Sónia Bernardo; Sofia Saraiva; Ana Rita Gonçalves; Paula Moura Santos; Ana Valente; Luís Araújo Correia; Helena Cortez-Pinto; Fernando Magro. "The degree of bowel remission predicts phenotype progression in Crohn's disease". United European Gastroenterology Journal (2024): https://doi.org/10.1002/ueg2.12581.
    10.1002/ueg2.12581
  3. Samuel Raimundo Fernandes; Sónia Bernardo; Sofia Saraiva; Ana Rita Gonçalves; Paula Moura Santos; Ana Valente; Luís Araújo Correia; Helena Cortez-Pinto; Fernando Magro. "Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease". United European Gastroenterology Journal (2024): https://doi.org/10.1002/ueg2.12497.
    10.1002/ueg2.12497
  4. Lise Retat; Laura Webber; Peter Jepsen; Alexander Martin; Helena Cortez-Pinto; Jeffrey V. Lazarus; Francesco Negro; et al. "Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study". Journal of Hepatology (2024): https://doi.org/10.1016/j.jhep.2023.11.021.
    10.1016/j.jhep.2023.11.021
  5. Cespiati, Annalisa; Coelho Rodrigues, Inês; Santos, Inês; Policarpo, Sara; Carvalhana, Sofia; Fracanzani, Anna Ludovica; Cortez-Pinto, Helena. "Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review". Liver International 44 5 (2024): 1075-1092. https://doi.org/10.1111/liv.15876.
    10.1111/liv.15876
  6. Vacca, M.; Kamzolas, I.; Harder, L.M.; Oakley, F.; Trautwein, C.; Hatting, M.; Ross, T.; et al. "An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)". Nature Metabolism (2024): http://www.scopus.com/inward/record.url?eid=2-s2.0-85195930089&partnerID=MN8TOARS.
    10.1038/s42255-024-01043-6
  7. Romero-Gómez, M.; Arab, J.P.; Oliveira, C.P.; Hernández, M.; Arrese, M.; Cortez-Pinto, H.; Bataller, R.. "Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?". Seminars in Liver Disease 44 1 (2024): 69-78. http://www.scopus.com/inward/record.url?eid=2-s2.0-85190138882&partnerID=MN8TOARS.
    10.1055/s-0044-1785228
  8. Liu, J.; MacNaughtan, J.; Kerbert, A.J.C.; Portlock, T.; Gonzalez, J.M.; Jin, Y.; Clasen, F.; et al. "Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis". Gut (2024): http://www.scopus.com/inward/record.url?eid=2-s2.0-85191370362&partnerID=MN8TOARS.
    10.1136/gutjnl-2023-330699
  9. Serrazina, J.; Cortez-Pinto, H.. "Shaping new paths in clinical trial design to address alcohol use disorders and alcohol-associated liver disease". Nature Reviews Gastroenterology and Hepatology (2024): http://www.scopus.com/inward/record.url?eid=2-s2.0-85195483689&partnerID=MN8TOARS.
    10.1038/s41575-024-00948-7
  10. Vlad Ratziu; Sven Francque; Cynthia A. Behling; Vanja Cejvanovic; Helena Cortez-Pinto; Janani S. Iyer; Niels Krarup; et al. "Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis". Hepatology (2023): https://doi.org/10.1097/HEP.0000000000000723.
    10.1097/HEP.0000000000000723
  11. Samuel Raimundo Fernandes; Sónia Bernardo; Sofia Saraiva; Ana Rita Gonçalves; Paula Moura Santos; Ana Valente; Luís Araújo Correia; Helena Cortez-Pinto; Fernando Magro. "Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn’s Disease: A Propensity Score–Matched Analysis". Inflammatory Bowel Diseases (2023): https://doi.org/10.1093/ibd/izad272.
    10.1093/ibd/izad272
  12. Ana Craciun; Inês Botto; Joao Lopes; Miguel Moura; Sofia Carvalhana; Helena Cortez-Pinto; Rui Tato Marinho. "Influence of COVID-19 on Patients with Esophageal Varices under Prophylactic Endoscopic Band Ligation Therapy". GE - Portuguese Journal of Gastroenterology (2023): https://doi.org/10.1159/000531135.
    10.1159/000531135
  13. Simão, André Lopes; Palma, Carolina Santos; Izquierdo-Sanchez, Laura; Putignano, Antonella; Carvalho-Gomes, Angela; Posch, Andreas; Zanaga, Paola; et al. "Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease". JHEP Reports (2023): 100697. http://dx.doi.org/10.1016/j.jhepr.2023.100697.
    10.1016/j.jhepr.2023.100697
  14. Einar S. Björnsson; Camilla Stephens; Edmond Atallah; Mercedes Robles-Diaz; Ismael Alvarez-Alvarez; Alexander Gerbes; Sabine Weber; et al. "A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry". Liver International (2023): https://doi.org/10.1111/liv.15378.
    10.1111/liv.15378
  15. Simao, Andre L.; Fernandes, Diogo A. E.; Silva, Daniela; Cruz, Margarida; Afonso, Marta B.; Santos, Andre A.; Moura Henrique, Mariana; et al. "Role of TGR5 in fat-to-liver communication during NAFLD". Journal of Hepatology (2023): https://publons.com/wos-op/publon/63816810/.
  16. Lazarus, J.V.; Mark, H.E.; Allen, A.M.; Arab, J.P.; Carrieri, P.; Noureddin, M.; Alazawi, W.; et al. "A global action agenda for turning the tide on fatty liver disease". Hepatology (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85169126126&partnerID=MN8TOARS.
    10.1097/HEP.0000000000000545
  17. Mózes, F.E.; Lee, J.A.; Vali, Y.; Alzoubi, O.; Staufer, K.; Trauner, M.; Paternostro, R.; et al. "Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis". The Lancet Gastroenterology and Hepatology 8 8 (2023): 704-713. http://www.scopus.com/inward/record.url?eid=2-s2.0-85162866470&partnerID=MN8TOARS.
    10.1016/S2468-1253(23)00141-3
  18. Lee, J.; Westphal, M.; Vali, Y.; Boursier, J.; Petta, S.; Ostroff, R.; Alexander, L.; et al. "Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study". Hepatology 78 1 (2023): 258-271. http://www.scopus.com/inward/record.url?eid=2-s2.0-85163490526&partnerID=MN8TOARS.
    10.1097/HEP.0000000000000364
  19. Vali, Y.; Lee, J.; Boursier, J.; Petta, S.; Wonders, K.; Tiniakos, D.; Bedossa, P.; et al. "Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study". The Lancet Gastroenterology and Hepatology 8 8 (2023): 714-725. http://www.scopus.com/inward/record.url?eid=2-s2.0-85150789965&partnerID=MN8TOARS.
    10.1016/S2468-1253(23)00017-1
  20. Fernandes, S.R.; Serrazina, J.; Botto, I.A.; Leal, T.; Guimarães, A.; Garcia, J.L.; Rosa, I.; et al. "Transmural remission improves clinical outcomes up to 5 years in Crohn's disease". United European Gastroenterology Journal 11 1 (2023): 51-59. http://www.scopus.com/inward/record.url?eid=2-s2.0-85145289034&partnerID=MN8TOARS.
    10.1002/ueg2.12356
  21. Rinella, M.E.; Lazarus, J.V.; Ratziu, V.; Francque, S.M.; Sanyal, A.J.; Kanwal, F.; Romero, D.; et al. "A multisociety Delphi consensus statement on new fatty liver disease nomenclature". Hepatology 78 6 (2023): 1966-1986. http://www.scopus.com/inward/record.url?eid=2-s2.0-85177103214&partnerID=MN8TOARS.
    10.1097/HEP.0000000000000520
  22. Lazarus, J.V.; Mark, H.E.; Allen, A.M.; Arab, J.P.; Carrieri, P.; Noureddin, M.; Alazawi, W.; et al. "A global research priority agenda to advance public health responses to fatty liver disease". Journal of Hepatology 79 3 (2023): 618-634. http://www.scopus.com/inward/record.url?eid=2-s2.0-85165924387&partnerID=MN8TOARS.
    10.1016/j.jhep.2023.04.035
  23. Koletzko, B.; Cortez-Pinto, H.; Löhr, M.; van Hooft, J.; Rosendahl, J.. "Medical guidelines must not be influenced by commercial interests". United European gastroenterology journal 11 6 (2023): 582-583. http://www.scopus.com/inward/record.url?eid=2-s2.0-85164626073&partnerID=MN8TOARS.
    10.1002/ueg2.12416
  24. Huang, D.Q.; Mathurin, P.; Cortez-Pinto, H.; Loomba, R.. "Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors". Nature Reviews Gastroenterology and Hepatology 20 1 (2023): 37-49. http://www.scopus.com/inward/record.url?eid=2-s2.0-85140123239&partnerID=MN8TOARS.
    10.1038/s41575-022-00688-6
  25. Zhou, X.-D.; Targher, G.; Byrne, C.D.; Somers, V.; Kim, S.U.; Chahal, C.A.A.; Wong, V.W.-S.; et al. "An international multidisciplinary consensus statement on MAFLD and the risk of CVD". Hepatology International 17 4 (2023): 773-791. http://www.scopus.com/inward/record.url?eid=2-s2.0-85159655410&partnerID=MN8TOARS.
    10.1007/s12072-023-10543-8
  26. Rodrigues, B.; Carraça, E.V.; Francisco, B.B.; Nobre, I.; Cortez-Pinto, H.; Santos, I.. "Theory-based physical activity and/or nutrition behavior change interventions for cancer survivors: a systematic review". Journal of Cancer Survivorship (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85158159206&partnerID=MN8TOARS.
    10.1007/s11764-023-01390-5
  27. Ravindra, K.C.; Vaidya, V.S.; Wang, Z.; Federspiel, J.D.; Virgen-Slane, R.; Everley, R.A.; Grove, J.I.; et al. "Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans". Nature Communications 14 1 (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85149550360&partnerID=MN8TOARS.
    10.1038/s41467-023-36858-6
  28. Mariana Verdelho Machado; Helena Cortez-Pinto. "NAFLD, MAFLD and obesity: brothers in arms?". Nature Reviews Gastroenterology & Hepatology (2022): https://doi.org/10.1038/s41575-022-00717-4.
    10.1038/s41575-022-00717-4
  29. Helena Cortez-Pinto; Jeanin van Hooft; Berthold Koletzko; Johannes-Matthias Löhr. "UEG's prospects for the future". United European Gastroenterology Journal (2022): https://doi.org/10.1002/ueg2.12335.
    10.1002/ueg2.12335
  30. João, Mafalda; Carvalhana, Sofia; Moura, Miguel; Freitas, Luís Carlos; Silva, Andrea; Figueiredo, Pedro; Liberal, Rodrigo; et al. "Severe acute autoimmune hepatitis: How to early predict who will not respond to corticosteroids and needs urgent liver transplantation?". Digestive and Liver Disease 54 12 (2022): 1681-1685. https://doi.org/10.1016/j.dld.2022.08.035.
    10.1016/j.dld.2022.08.035
  31. Helena Cortez-Pinto. "My UEG Presidency: Providing opportunities for professionals to enhance their knowledge and skills and ultimately contribute to the improvement of digestive health". United European Gastroenterology Journal 10 2 (2022): 233-234. https://doi.org/10.1002/ueg2.12210.
    10.1002/ueg2.12210
  32. Sara Policarpo; sofia carvalhana; Ana Craciun; Ricardo Rios Crespo; Helena Cortez-Pinto. "Do MAFLD Patients with Harmful Alcohol Consumption Have a Different Dietary Intake?". Nutrients (2022): https://www.mdpi.com/2072-6643/14/7/1335.
    10.3390/nu14071335
  33. Ventura-Cots, Meritxell; Argemi, Josepmaria; Jones, Patricia D; Lackner, Carolin; El Hag, Mohamed; Abraldes, Juan G; Alvarado, Edilmar; et al. "Clinical, histological and molecular profiling of different stages of alcohol-related liver disease". (2022): http://hdl.handle.net/10451/51101.
    10.1136/gutjnl-2021-324295
  34. Craciun, A.; Cortez-Pinto, H.. "Alarming increase of NASH as cause of liver cancer". Cell Reports Medicine 3 8 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85135944318&partnerID=MN8TOARS.
    10.1016/j.xcrm.2022.100723
  35. Lazarus, J.V.; Mark, H.E.; Villota-Rivas, M.; Palayew, A.; Carrieri, P.; Colombo, M.; Ekstedt, M.; et al. "The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?". Journal of Hepatology 76 4 (2022): 771-780. http://www.scopus.com/inward/record.url?eid=2-s2.0-85122443139&partnerID=MN8TOARS.
    10.1016/j.jhep.2021.10.025
  36. Mózes, F.E.; Lee, J.A.; Selvaraj, E.A.; Jayaswal, A.N.A.; Trauner, M.; Boursier, J.; Fournier, C.; et al. "Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis". Gut 71 5 (2022): 1006-1019. http://www.scopus.com/inward/record.url?eid=2-s2.0-85106947127&partnerID=MN8TOARS.
    10.1136/gutjnl-2021-324243
  37. Farahat, T.M.; Ungan, M.; Vilaseca, J.; Ponzo, J.; Gupta, P.P.; Schreiner, A.D.; Al Sharief, W.; et al. "The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint". Liver International 42 6 (2022): 1259-1267. http://www.scopus.com/inward/record.url?eid=2-s2.0-85126012121&partnerID=MN8TOARS.
    10.1111/liv.15188
  38. Karlsen, T.H.; Sheron, N.; Zelber-Sagi, S.; Carrieri, P.; Dusheiko, G.; Bugianesi, E.; Pryke, R.; et al. "The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality". The Lancet 399 10319 (2022): 61-116. http://www.scopus.com/inward/record.url?eid=2-s2.0-85121502917&partnerID=MN8TOARS.
    10.1016/S0140-6736(21)01701-3
  39. Sara Raquel Osório Policarpo; Mariana V. Machado; David Barreira; Helena Cortez-Pinto. "NAFLD Nutritional Management: Results from a Multidisciplinary Approach". GE - Portuguese Journal of Gastroenterology (2021): https://doi.org/10.1159/000519932.
    10.1159/000519932
  40. Lazarus, Jeffrey V.; Mark, Henry E.; Anstee, Quentin M.; Arab, Juan Pablo; Batterham, Rachel L.; Castera, Laurent; Cortez-Pinto, Helena; et al. "Advancing the global public health agenda for NAFLD: a consensus statement". Nature Reviews Gastroenterology & Hepatology 19 1 (2021): 60-78. http://dx.doi.org/10.1038/s41575-021-00523-4.
    10.1038/s41575-021-00523-4
  41. Helena Cortez-Pinto; Rodrigo Liberal; Susana Lopes; Mariana V. Machado; Joana Carvalho; Teresa Dias; Arsénio Santos; et al. "Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease". United European Gastroenterology Journal 9 6 (2021): 699-706. https://doi.org/10.1002/ueg2.12095.
    10.1002/ueg2.12095
  42. Hirschfield, Gideon M; Chazouillères, Olivier; Cortez-Pinto, Helena; Macedo, Guilherme; de Lédinghen, Victor; Adekunle, Femi; Carbone, Marco. "A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients". Expert Review of Gastroenterology & Hepatology 15 8 (2021): 929-939. http://dx.doi.org/10.1080/17474124.2021.1945919.
    10.1080/17474124.2021.1945919
  43. Lazarus, Jeffrey V.; Anstee, Quentin M.; Hagström, Hannes; Cusi, Kenneth; Cortez-Pinto, Helena; Mark, Henry E.; Roden, Michael; et al. "Defining comprehensive models of care for NAFLD". Nature Reviews Gastroenterology & Hepatology 18 10 (2021): 717-729. http://dx.doi.org/10.1038/s41575-021-00477-7.
    10.1038/s41575-021-00477-7
  44. Marques, Vanda; Afonso, Marta B.; Bierig, Nina; Duarte-Ramos, Filipa; Santos-Laso, Álvaro; Jimenez-Agüero, Raul; Eizaguirre, Emma; et al. "Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD". Frontiers in Medicine 8 (2021): 683250.
    Published • 10.3389/fmed.2021.683250
  45. Marques de Sá, Inês; Bibi, Mário; Moura, Miguel; Carvalhana, Sofia; Cortez-Pinto, Helena; Marques De Sá, I.; Bibi, M.; et al. "No evidence of benefit of routine ascitic fluid analysis in refractory ascites undergoing therapeutic paracentesis". European Journal of Gastroenterology & Hepatology 33 6 (2021): 942-942. https://doi.org/10.1097/meg.0000000000002119.
    10.1097/meg.0000000000002119
  46. Sónia Bernardo; Rudolf E. Stauber; Ricardo Crespo; Sofia Saraiva; Rui Barata; Sara Gonçalves; Paulo Nogueira; Helena Cortez-Pinto; Mariana Verdelho Machado. "Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality". PLOS ONE (2021): https://doi.org/10.1371/journal.pone.0252218.
    10.1371/journal.pone.0252218
  47. Vanholder, Raymond; Domínguez-Gil, Beatriz; Busic, Mirela; Cortez-Pinto, Helena; Craig, Jonathan C.; Jager, Kitty J.; Mahillo, Beatriz; et al. "Organ donation and transplantation: a multi-stakeholder call to action". Nature Reviews Nephrology 17 8 (2021): 554-568. http://dx.doi.org/10.1038/s41581-021-00425-3.
    10.1038/s41581-021-00425-3
  48. Lackner, C.; Stauber, R.E.; Davies, S.; Denk, H.; Dienes, H.P.; Gnemmi, V.; Guido, M.; et al. "Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease". Journal of Hepatology 75 4 (2021): 810-819. http://www.scopus.com/inward/record.url?eid=2-s2.0-85113329223&partnerID=MN8TOARS.
    10.1016/j.jhep.2021.05.029
  49. Policarpo, S.; Machado, M.V.; Cortez-Pinto, H.. "Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: A randomized controlled trial". Clinical Nutrition ESPEN 43 (2021): 329-334. http://www.scopus.com/inward/record.url?eid=2-s2.0-85106282449&partnerID=MN8TOARS.
    10.1016/j.clnesp.2021.03.031
  50. Duffell, E.; Cortez-Pinto, H.; Simonova, M.; Dalgard, O.; Dahl, E.H.; de Martel, C.; Mozalevskis, A.; et al. "Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C". Journal of Viral Hepatitis 28 8 (2021): 1177-1189. http://www.scopus.com/inward/record.url?eid=2-s2.0-85107529050&partnerID=MN8TOARS.
    10.1111/jvh.13545
  51. Dignass, A.; Cortez-Pinto, H.. "Join the myUEG community and become an official myUEG Associate for free". United European gastroenterology journal 9 10 (2021): 1191-1192. http://www.scopus.com/inward/record.url?eid=2-s2.0-85122770877&partnerID=MN8TOARS.
    10.1002/ueg2.12179
  52. Selvaraj, E.A.; Mózes, F.E.; Jayaswal, A.N.A.; Zafarmand, M.H.; Vali, Y.; Lee, J.A.; Levick, C.K.; et al. "Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis". Journal of Hepatology 75 4 (2021): 770-785. http://www.scopus.com/inward/record.url?eid=2-s2.0-85108940286&partnerID=MN8TOARS.
    10.1016/j.jhep.2021.04.044
  53. Lazarus, J.V.; Palayew, A.; Carrieri, P.; Ekstedt, M.; Marchesini, G.; Novak, K.; Ratziu, V.; et al. "European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?". JHEP Reports 3 2 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85101757591&partnerID=MN8TOARS.
    10.1016/j.jhepr.2021.100234
  54. Reis, Daniela; Moura, Miguel; Freitas, Luís Carlos; Carvalhana, Sofia; Nogueira, Paulo Jorge; Gaio, Raquel; Marinho, Rui Tato; Cortez-Pinto, Helena. "Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib". European Journal of Gastroenterology & Hepatology Publish Ah (2020): http://dx.doi.org/10.1097/meg.0000000000001974.
    10.1097/meg.0000000000001974
  55. Hardy, Timothy; Wonders, Kristy; Younes, Ramy; Aithal, Guruprasad P.; Aller, Rocio; Allison, Michael; Bedossa, Pierre; et al. "The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease". Contemporary Clinical Trials 98 (2020): 106175. http://dx.doi.org/10.1016/j.cct.2020.106175.
    Published • 10.1016/j.cct.2020.106175
  56. Jeffrey V. Lazarus; Massimo Colombo; Helena Cortez-Pinto; Terry T. -K. Huang; Veronica Miller; Michael Ninburg; Jörn M. Schattenberg; et al. "NAFLD — sounding the alarm on a silent epidemic". Nature Reviews Gastroenterology & Hepatology (2020): https://doi.org/10.1038/s41575-020-0315-7.
    10.1038/s41575-020-0315-7
  57. Ana Craciun; Caroline Lackner; Helena Cortez-Pinto. "Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?". Current Pharmaceutical Design 26 (2020): https://doi.org/10.2174/1381612826666200122152417.
    10.2174/1381612826666200122152417
  58. Leitão, Jorge; Carvalhana, Sofia; Cochicho, Joana; Silva, Ana Paula; Velasco, Francisco; Medeiros, Isabel; Alves, Ana Catarina; et al. "Prevalence and risk factors of fatty liver in Portuguese adults". European Journal of Clinical Investigation (2020): http://dx.doi.org/10.1111/eci.13235.
    10.1111/eci.13235
  59. Jeffrey V. Lazarus; Helena Cortez-Pinto; Quentin M. Anstee. "Reply to: “Caveats for the implementation of global strategies against non-alcoholic fatty liver disease”". Journal of Hepatology (2020): https://doi.org/10.1016/j.jhep.2020.03.017.
    10.1016/j.jhep.2020.03.017
  60. Eslam, Mohammed; Newsome, Philip N.; Anstee, Quentin M.; Targher, Giovanni; Gomez, Manuel Romero; Zelber-Sagi, Shira; Wong, Vincent Wai-Sun; et al. "A new definition for metabolic associated fatty liver disease: an international expert consensus statement". Journal of Hepatology (2020): http://dx.doi.org/10.1016/j.jhep.2020.03.039.
    10.1016/j.jhep.2020.03.039
  61. Eslam, Mohammed; Sanyal, Arun J.; George, Jacob; Sanyal, Arun; Neuschwander-Tetri, Brent; Tiribelli, Claudio; Kleiner, David E.; et al. "MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease". Gastroenterology (2020): http://dx.doi.org/10.1053/j.gastro.2019.11.312.
    10.1053/j.gastro.2019.11.312
  62. Carlos Noronha Ferreira; Helena Cortez-Pinto; José Velosa; Rui Tato Marinho. "Inadvertent oversight while reporting factors predicting decompensation of cirrhosis". Liver International (2020): https://doi.org/10.1111/liv.14287.
    10.1111/liv.14287
  63. Marques da Costa, Pedro; Tato Marinho, Rui; Cortez-Pinto, Helena; Costa, Luís; Velosa, José; Marinho, Rui. "Twenty-Five Years of Increasing Mortality From Pancreatic Cancer in Portugal". Pancreas 49 1 (2020): e2-e3. http://dx.doi.org/10.1097/mpa.0000000000001446.
    10.1097/mpa.0000000000001446
  64. Lazarus, Jeffrey V.; Ekstedt, Mattias; Marchesini, Giulio; Mullen, Jillian; Novak, Katja; Pericàs, Juan M.; Roel, Elena; et al. "A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe". Journal of Hepatology 72 1 (2020): 14-24. http://dx.doi.org/10.1016/j.jhep.2019.08.027.
    10.1016/j.jhep.2019.08.027
  65. Avila, Matias A; Dufour, Jean-François; Gerbes, Alexander L; Zoulim, Fabien; Bataller, Ramon; Burra, Patrizia; Cortez-Pinto, Helena; et al. "Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting". Gut 69 4 (2019): 764-780. http://dx.doi.org/10.1136/gutjnl-2019-319720.
    10.1136/gutjnl-2019-319720
  66. Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; et al. "Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial". The Lancet 394 10215 (2019): 2184-2196. http://dx.doi.org/10.1016/s0140-6736(19)33041-7.
    10.1016/s0140-6736(19)33041-7
  67. Marchesini, Giulio; Petroni, Maria Letizia; Cortez-Pinto, Helena. "Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?". Journal of Hepatology 71 6 (2019): 1073-1075. http://dx.doi.org/10.1016/j.jhep.2019.09.020.
    10.1016/j.jhep.2019.09.020
  68. Machado, Mariana V.; Policarpo, Sara; Coutinho, J; Carvalhana, Sofia; Leitão, Jorge; Carvalho, Armando; Silva, Ana P.; et al. "What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?". Obesity Surgery 30 2 (2019): 560-568. http://dx.doi.org/10.1007/s11695-019-04213-8.
    10.1007/s11695-019-04213-8
  69. Carlos Noronha Ferreira; Helena Cortez-Pinto; Fátima Serejo; José Velosa; Rui Tato Marinho. "Anticoagulation in patients with cirrhosis and portal vein thrombosis: Safety and beneficial effect on OLT-free survival". Liver International 39 10 (2019): 2002-2002. https://doi.org/10.1111/liv.14231.
    10.1111/liv.14231
  70. Vasques, João; Guerreiro, Catarina Sousa; Sousa, Joana; Pinto, Mariana; Cortez-Pinto, Helena. "Nutritional support in cirrhotic patients with sarcopenia". Clinical Nutrition ESPEN 33 (2019): 12-17. http://dx.doi.org/10.1016/j.clnesp.2019.07.011.
    10.1016/j.clnesp.2019.07.011
  71. Shah, Neil D.; Ventura-Cots, Meritxell; Abraldes, Juan G.; Alboraie, Mohamed; Alfadhli, Ahmad; Argemi, Josepmaria; Badia-Aranda, Ester; et al. "Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide". Clinical Gastroenterology and Hepatology 17 11 (2019): 2320-2329.e12. http://dx.doi.org/10.1016/j.cgh.2019.01.026.
    10.1016/j.cgh.2019.01.026
  72. Carlos Noronha Ferreira; Rui T. Marinho; Helena Cortez-Pinto; Paula Ferreira; Margarida S. Dias; Mariana Vasconcelos; Paula Alexandrino; et al. "Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study". Liver International (2019): https://doi.org/10.1111/liv.14121.
    10.1111/liv.14121
  73. Simão, André L.; Afonso, Marta B.; Rodrigues, Pedro M.; Gama-Carvalho, Margarida; Machado, Mariana V.; Cortez-Pinto, Helena; Rodrigues, Cecília M. P.; Castro, Rui E.. "Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis". Journal of Molecular Medicine 97 8 (2019): 1113-1126. http://dx.doi.org/10.1007/s00109-019-01796-8.
    10.1007/s00109-019-01796-8
  74. Arab, Juan P.; Roblero, Juan P.; Altamirano, Jose; Bessone, Fernando; Chaves Araujo, Roberta; Higuera-De la Tijera, Fatima; Restrepo, Juan Carlos; et al. "Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)". Annals of Hepatology 18 3 (2019): 518-535. http://dx.doi.org/10.1016/j.aohep.2019.04.005.
    10.1016/j.aohep.2019.04.005
  75. Noronha Ferreira, Carlos; Reis, Daniela; Cortez-Pinto, Helena; Tato Marinho, Rui; Gonçalves, Afonso; Palma, Sónia; Leite, Inês; et al. "Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis". Digestive Diseases and Sciences 64 9 (2019): 2671-2683. http://dx.doi.org/10.1007/s10620-019-05572-z.
    10.1007/s10620-019-05572-z
  76. Szabo, Gyongyi; Kamath, Patrick S.; Shah, Vijay H.; Thursz, Mark; Mathurin, Philippe; Addolorato, Giovanni; Bataller, Ramon; et al. "Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study". Hepatology 69 5 (2019): 2271-2283. http://dx.doi.org/10.1002/hep.30369.
    10.1002/hep.30369
  77. Bazerbachi, Fateh; Haffar, Samir; Wang, Zhen; Cabezas, Joaquín; Arias-Loste, Maria Teresa; Crespo, Javier; Darwish-Murad, Sarwa; et al. "Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals". Clinical Gastroenterology and Hepatology 17 1 (2019): 54-64.e1. http://dx.doi.org/10.1016/j.cgh.2018.08.069.
    10.1016/j.cgh.2018.08.069
  78. Joana Rita Carvalho; Mariana Vasconcelos; Pedro Marques da Costa; Rui Tato Marinho; Narcisa Fatela; Miguel Raimundo; Sofia Carvalhana; et al. "Identifying palliative care needs in a Portuguese liver unit". Liver International (2018): https://doi.org/10.1111/liv.13865.
    10.1111/liv.13865
  79. Pimpin, Laura; Cortez-Pinto, Helena; Negro, Francesco; Corbould, Emily; Lazarus, Jeffrey V.; Webber, Laura; Sheron, Nick. "Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies". Journal of Hepatology 69 3 (2018): 718-735. http://dx.doi.org/10.1016/j.jhep.2018.05.011.
    10.1016/j.jhep.2018.05.011
  80. Seitz, Helmut K.; Bataller, Ramon; Cortez-Pinto, Helena; Gao, Bin; Gual, Antoni; Lackner, Carolin; Mathurin, Philippe; et al. "Alcoholic liver disease". Nature Reviews Disease Primers 4 1 (2018): http://dx.doi.org/10.1038/s41572-018-0014-7.
    10.1038/s41572-018-0014-7
  81. Pedro Marques da Costa; Inês Martins; Joaquim Neves; Helena Cortez-Pinto; José Velosa; Marques da Costa, Pedro; Martins, Inês; et al. "Serum Vitamin D Levels Correlate With The Presence And Histological Grading Of Colorectal Adenomas In Peri And Postmenopausal Women". Clinical Nutrition 38 3 (2018): 1390-1397. https://doi.org/10.1016/j.clnu.2018.06.959.
    10.1016/j.clnu.2018.06.959
  82. Leitão, Jorge; Carvalhana, Sofia; Silva, Ana Paula; Velasco, Francisco; Medeiros, Isabel; Alves, Ana Catarina; Bourbon, Mafalda; et al. "No Evidence for Lower Levels of Serum Vitamin D in the Presence of Hepatic Steatosis. A Study on the Portuguese General Population". (2018): http://hdl.handle.net/10400.18/5932.
    10.7150/ijms.26586
  83. Papatheodoridis, G.V.; Hatzakis, A.; Cholongitas, E.; Baptista-Leite, R.; Baskozos, I.; Chhatwal, J.; Colombo, M.; et al. "Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe". Journal of Viral Hepatitis 25 (2018): 6-17. http://www.scopus.com/inward/record.url?eid=2-s2.0-85043346583&partnerID=MN8TOARS.
    10.1111/jvh.12875
  84. Nascimbeni, F.; Ballestri, S.; Machado, M.V.; Mantovani, A.; Cortez-Pinto, H.; Targher, G.; Lonardo, A.. "Clinical relevance of liver histopathology and different histological classifications of NASH in adults". Expert Review of Gastroenterology and Hepatology 12 4 (2018): 351-367. http://www.scopus.com/inward/record.url?eid=2-s2.0-85043981098&partnerID=MN8TOARS.
    10.1080/17474124.2018.1415756
  85. Seitz, H.K.; Bataller, R.; Cortez-Pinto, H.; Gao, B.; Gual, A.; Lackner, C.; Mathurin, P.; et al. "Erratum to: Alcoholic liver disease (Nature Reviews Disease Primers, (2018), 4, 1, (16), 10.1038/s41572-018-0014-7)". Nature Reviews Disease Primers 4 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85052372003&partnerID=MN8TOARS.
    10.1038/s41572-018-0021-8
  86. Bernardo, Sónia; Carvalhana, Sofia; Antunes, Teresa; Ferreira, Paula; Cortez-Pinto, Helena; Velosa, José. "A rare cause of acute liver failure- a case report". BMC Gastroenterology 17 1 (2017): http://dx.doi.org/10.1186/s12876-017-0730-6.
    10.1186/s12876-017-0730-6
  87. Fernandes, Samuel R.; Marques da Costa, Pedro; Vítor, Sofia; Carvalho, Joana R.; Santos, Patrícia; Moura, Carlos M.; Cortez-Pinto, Helena; Ramalho, Fernando; Velosa, José. "Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis". European Journal of Gastroenterology & Hepatology 29 10 (2017): 1141-1148. http://dx.doi.org/10.1097/meg.0000000000000926.
    10.1097/meg.0000000000000926
  88. Rodrigues, Pedro M; Afonso, Marta B; Simão, André L; Carvalho, Catarina C; Trindade, Alexandre; Duarte, António; Borralho, Pedro M; et al. "Erratum: miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice". Cell Death & Disease 8 5 (2017): e2825-e2825. http://dx.doi.org/10.1038/cddis.2017.246.
    10.1038/cddis.2017.246
  89. Chora, Joana Rita; Alves, Ana Catarina; Medeiros, Ana Margarida; Mariano, Cibelle; Lobarinhas, Goreti; Guerra, António; Mansilha, Helena; Cortez-Pinto, Helena; Bourbon, Mafalda. "Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?". Journal of Clinical Lipidology 11 2 (2017): 477-484.e2. http://dx.doi.org/10.1016/j.jacl.2016.11.002.
    10.1016/j.jacl.2016.11.002
  90. Telles-Correia, Diogo; Barbosa, António; Cortez-Pinto, Helena; Campos, Carlos; Rocha, Nuno B F; Machado, Sérgio; Rocha, Nuno. "Psychotropic drugs and liver disease : a critical review of pharmacokinetics and liver toxicity". (2017): http://hdl.handle.net/10451/45820.
    10.4292/wjgpt.v8.i1.26
  91. Romero-Gómez, M.; Cortez-Pinto, H.. "Detecting liver fat from viscoelasticity: How good is CAP in clinical practice? The need for universal cut-offs". Journal of Hepatology 66 5 (2017): 886-887. http://www.scopus.com/inward/record.url?eid=2-s2.0-85014733337&partnerID=MN8TOARS.
    10.1016/j.jhep.2017.01.029
  92. Rodrigues, P.M.; Afonso, M.B.; Simaõ, A.L.; Carvalho, C.C.; Trindade, A.; Duarte, A.; Borralho, P.M.; et al. "MiR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice". Cell Death and Disease 8 4 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85017474560&partnerID=MN8TOARS.
    10.1038/cddis.2017.172
  93. Fernandes, S.R.; Marques Da Costa, P.; Vítor, S.; Carvalho, J.R.; Santos, P.; Moura, C.M.; Cortez-Pinto, H.; Ramalho, F.; Velosa, J.. "Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis". European Journal of Gastroenterology and Hepatology 29 10 (2017): 1141-1148. http://www.scopus.com/inward/record.url?eid=2-s2.0-85021152888&partnerID=MN8TOARS.
    10.1097/MEG.0000000000000926
  94. Caldwell, S.; Intagliata, N.; Gatt, A.; Reuben, A.; Farias, A.; Lackner, C.; Eby, C.; et al. "A summary of the 6th international conference on coagulation in liver disease: Discussion, debate, deliberations". Annals of Hepatology 16 1 (2017): 12-15. http://www.scopus.com/inward/record.url?eid=2-s2.0-85007557099&partnerID=MN8TOARS.
    10.5604/16652681.1226811
  95. Bugianesi, E.; Rosso, C.; Cortez-Pinto, H.. "How to diagnose NAFLD in 2016". Journal of Hepatology 65 3 (2016): 643-644. http://dx.doi.org/10.1016/j.jhep.2016.05.038.
    10.1016/j.jhep.2016.05.038
  96. Fernandes, Samuel Raimundo; Alves, Antonio T; Cortes, Margarida Barreto; Cortez-Pinto, Helena. "Graft-versus-host disease: unexpected presentation with simultaneous hepatitis and pancreatitis". BMJ Case Reports (2016): bcr2016215940. http://dx.doi.org/10.1136/bcr-2016-215940.
    10.1136/bcr-2016-215940
  97. Carvalhana, Sofia C.; Leitão, Jorge; Alves, Ana C.; Bourbon, Mafalda; Cortez-Pinto, Helena. "Hepatitis B and C prevalence in Portugal". European Journal of Gastroenterology & Hepatology 28 6 (2016): 640-644. http://dx.doi.org/10.1097/meg.0000000000000608.
    10.1097/meg.0000000000000608
  98. Lonardo, A.; Byrne, C.D.; Caldwell, S.H.; Cortez-Pinto, H.; Targher, G.. "Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes". Hepatology 64 4 (2016): 1388-1389. http://dx.doi.org/10.1002/hep.28584.
    10.1002/hep.28584
  99. Machado, Mariana; Cortez-Pinto, Helena; Cortez-Pinto, Helena. "Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet". International Journal of Molecular Sciences 17 4 (2016): 481. http://dx.doi.org/10.3390/ijms17040481.
    10.3390/ijms17040481
  100. Fernandes, Samuel Raimundo; Correia, Luís Araújo; Antunes, Teresa; Cortez-Pinto, Helena. "Intraductal papillary mucinous neoplasm presenting with recurrent pancreatitis: a report of a painful 3-decade-long history". BMJ Case Reports (2016): bcr2016214640. http://dx.doi.org/10.1136/bcr-2016-214640.
    10.1136/bcr-2016-214640
  101. Fernandes, Samuel Raimundo; Moura, Carlos Miguel; Rodrigues, Beatriz; Correia, Luís Araújo; Cortez-Pinto, Helena; Velosa, José. "Acute cholangitis in an old patient with Crigler-Najjar syndrome type II - a case report". BMC Gastroenterology 16 1 (2016): http://dx.doi.org/10.1186/s12876-016-0449-9.
    10.1186/s12876-016-0449-9
  102. Cortez-Pinto, Helena; Borralho, Paula; Machado, Jorge; Lopes, Maria T.; Gato, Inês V.; Santos, António M.; Guerreiro, António S.; et al. "Microbiota Modulation With Synbiotic Decreases Liver Fibrosis in a High Fat Choline Deficient Diet Mice Model of Non-Alcoholic Steatohepatitis (NASH)". (2016): http://hdl.handle.net/10362/124600.
    https://doi.org/10.1016/j.jpge.2016.01.004
  103. Afonso, Marta; Rodrigues, Pedro; Simão, André; Ofengeim, Dimitry; Carvalho, Tânia; Amaral, Joana D.; Gaspar, Maria Manuela; et al. "Activation of necroptosis in human and experimental cholestasis". Cell Death & Disease 7 9 (2016): e2390-e2390. http://hdl.handle.net/10451/46134.
    10.1038/cddis.2016.280
  104. Pimenta, Nuno; Santa-Clara, Helena; Melo, Xavier; Cortez-Pinto, Helena; Silva Nunes, José António; Sardinha, Luis; Pimenta, N M; et al. "Waist-to-Hip Ratio is Related to Body Fat Content and Distribution Regardless of the Waist Circumference Measurement Protocol, in Non-Alcoholic Fatty Liver Disease Patients". International Journal of Sport Nutrition and Exercise Metabolism 26 4 (2016): 307-314. http://hdl.handle.net/10400.15/2149.
    10.1123/ijsnem.2014-0256
  105. Machado, M.V.; Cortez-Pinto, H.. "Obesity paradox in cirrhosis: is it real or just an illusion?". Liver International 36 10 (2016): 1412-1414. http://www.scopus.com/inward/record.url?eid=2-s2.0-84986243942&partnerID=MN8TOARS.
    10.1111/liv.13154
  106. Carvalhana, S.C.; Leitão, J.; Alves, A.C.; Bourbon, M.; Cortez-Pinto, H.. "Hepatitis B and C prevalence in Portugal: Disparity between the general population and high-risk groups". European Journal of Gastroenterology and Hepatology 28 6 (2016): 640-644. http://www.scopus.com/inward/record.url?eid=2-s2.0-84957837615&partnerID=MN8TOARS.
    10.1097/MEG.0000000000000608
  107. Machado, Mariana Verdelho; Michelotti, Gregory Alexander; Pereira, Thiago Almeida; Xie, Guanhua; Premont, Richard; Cortez-Pinto, Helena; Diehl, Anna Mae. "Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease". Journal of Hepatology 63 4 (2015): 962-970. http://dx.doi.org/10.1016/j.jhep.2015.05.031.
    10.1016/j.jhep.2015.05.031
  108. Machado, Mariana V.; Cortez-Pinto, Helena. "Proangiogenic factors in the development of HCC in alcoholic cirrhosis". Clinics and Research in Hepatology and Gastroenterology 39 (2015): S104-S108. http://dx.doi.org/10.1016/j.clinre.2015.06.001.
    10.1016/j.clinre.2015.06.001
  109. Afonso, Marta B.; Rodrigues, Pedro M.; Carvalho, Tânia; Caridade, Marta; Borralho, Paula; Cortez-Pinto, Helena; Castro, Rui E.; Rodrigues, Cecília M.P.. "Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis". Clinical Science 129 8 (2015): 721-739. http://dx.doi.org/10.1042/cs20140732.
    10.1042/cs20140732
  110. Loomba, Rohit; Cortez-Pinto, Helena. "Exercise and improvement of NAFLD: Practical recommendations". Journal of Hepatology 63 1 (2015): 10-12. http://dx.doi.org/10.1016/j.jhep.2015.03.009.
    10.1016/j.jhep.2015.03.009
  111. Telles-Correia, D.; João Freire, M.; Mega, I.; Barreiras, D.; Cortez Pinto, H.. "Anxiety and Depression Symptoms in Hepatic Encephalopathy: Are They Psychiatric or Organic?". Transplantation Proceedings 47 4 (2015): 1005-1007. http://dx.doi.org/10.1016/j.transproceed.2015.03.011.
    10.1016/j.transproceed.2015.03.011
  112. Cavalcante, Lourianne Nascimento. "Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal". World Journal of Hepatology 7 10 (2015): 1433. http://dx.doi.org/10.4254/wjh.v7.i10.1433.
    10.4254/wjh.v7.i10.1433
  113. Lonardo, A.; Bellentani, S.; Argo, C.K.; Ballestri, S.; Byrne, C.D.; Caldwell, S.H.; Cortez-Pinto, H.; et al. "Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups". Digestive and Liver Disease 47 12 (2015): 997-1006. http://www.scopus.com/inward/record.url?eid=2-s2.0-84983123731&partnerID=MN8TOARS.
    10.1016/j.dld.2015.08.004
  114. Ginès, P.; Beuers, U.; Cortez-Pinto, H.; Angsar, L.; Parès, A.. "Preface". Digestive diseases (Basel, Switzerland) 33 (2015): 1-1. http://www.scopus.com/inward/record.url?eid=2-s2.0-84977453364&partnerID=MN8TOARS.
    10.1159/000441135
  115. Machado, Mariana V.; Cortez-Pinto, Helena. "Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?". Liver International 34 9 (2014): 1291-1294. http://dx.doi.org/10.1111/liv.12578.
    10.1111/liv.12578
  116. Musso, Giovanni; Gambino, Roberto; Tabibian, James H.; Ekstedt, Mattias; Kechagias, Stergios; Hamaguchi, Masahide; Hultcrantz, Rolf; et al. "Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis". PLoS Medicine 11 7 (2014): e1001680. http://dx.doi.org/10.1371/journal.pmed.1001680.
    10.1371/journal.pmed.1001680
  117. Machado, Mariana V.; Janeiro, André; Miltenberger-Miltenyi, Gabriel; Cortez-Pinto, Helena. "Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis". European Journal of Gastroenterology & Hepatology 26 4 (2014): 438-443. http://dx.doi.org/10.1097/meg.0000000000000044.
    10.1097/meg.0000000000000044
  118. Machado, Mariana Verdelho; Cortez-Pinto, Helena. "Management of fatty liver disease with the metabolic syndrome". Expert Review of Gastroenterology & Hepatology 8 5 (2014): 487-500. http://dx.doi.org/10.1586/17474124.2014.903798.
    10.1586/17474124.2014.903798
  119. Machado, Mariana Verdelho. "Non-alcoholic fatty liver disease: What the clinician needs to know". World Journal of Gastroenterology 20 36 (2014): 12956. http://dx.doi.org/10.3748/wjg.v20.i36.12956.
    10.3748/wjg.v20.i36.12956
  120. MacHado, M.V.; Janeiro, A.; Miltenberger-Miltenyi, G.; Cortez-Pinto, H.. "Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis". European Journal of Gastroenterology and Hepatology 26 4 (2014): 438-443. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896396516&partnerID=MN8TOARS.
    10.1097/MEG.0000000000000044
  121. Carvalhana, Sofia; Leitão, Jorge; Alves, Ana C.; Bourbon, Mafalda; Cortez-Pinto, Helena. "How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound". Liver International 34 6 (2013): e111-e117. http://dx.doi.org/10.1111/liv.12305.
    10.1111/liv.12305
  122. Machado, Mariana Verdelho; Cortez-Pinto, Helena. "Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already?". Expert Review of Gastroenterology & Hepatology 7 6 (2013): 513-515. http://dx.doi.org/10.1586/17474124.2013.814903.
    10.1586/17474124.2013.814903
  123. Cortez-Pinto H; Machado MV. "Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.". (2013): http://europepmc.org/abstract/med/23183525.
    10.1016/j.jhep.2012.11.021
  124. Afonso MB; Borralho PM; Castro RE; Cortez-Pinto H; Ferreira DM; Machado MV; Rodrigues CM. "miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.". (2013): http://europepmc.org/abstract/med/22902550.
    10.1016/j.jhep.2012.08.008
  125. Alexandrino P; Cortez-Pinto H; Noronha Ferreira C; Ramalho F; Rodrigues T; Serejo F; Velosa J. "The new definition of acute kidney injury in patients with cirrhosis: a critical look.". (2012): http://europepmc.org/abstract/med/22287595.
    10.1136/gutjnl-2011-301951
  126. Carepa F; Cortez-Pinto H; Costa A; Coutinho J; Machado MV; Proença H. "How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.". (2012): http://europepmc.org/abstract/med/22735605.
    10.1097/MEG.0b013e32835609b0
  127. Carvalhana S; Cortez-Pinto H; Machado MV. "Improving dietary patterns in patients with nonalcoholic fatty liver disease.". (2012): http://europepmc.org/abstract/med/22878240.
    10.1097/MCO.0b013e3283566614
  128. Carvalhana, Sofia; Machado, Mariana Verdelho; Cortez-Pinto, Helena. "Improving dietary patterns in patients with nonalcoholic fatty liver disease". Current Opinion in Clinical Nutrition and Metabolic Care 15 5 (2012): 468-473. http://dx.doi.org/10.1097/mco.0b013e3283566614.
    10.1097/mco.0b013e3283566614
  129. Cortez-Pinto H; Machado MV. "NKT cells and the hedgehog pathway: an unhealthy marriage in non-alcoholic fatty liver disease?". (2012): http://europepmc.org/abstract/med/22490528.
    10.1136/gutjnl-2012-302378
  130. Cortez-Pinto, Helena; Thursz, Mark; Gual, Antoni; Lackner, Caroline; Mathurin, Philippe; Moreno, Christophe; Spahr, Laurent; Sterneck, Martina; Cortez-Pinto, Helena. "EASL clinical practical guidelines: management of alcoholic liver disease.". Journal of Hepatology 57 2 (2012): 399-420. http://europepmc.org/abstract/med/22633836.
    10.1016/j.jhep.2012.04.004
  131. Pena, Maria João; Ravasco, Paula; Machado, Mariana; Pinto, Anabela; Pinto, Susana; Rocha, Luz; de Carvalho, Mamede; Pinto, Helena Cortez. "What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis?". Amyotrophic Lateral Sclerosis 13 6 (2012): 550-554. http://dx.doi.org/10.3109/17482968.2012.684215.
    10.3109/17482968.2012.684215
  132. Cortez-Pinto, Helena; Cortez-Pinto H. "Alcoholic disease: understanding the scope of the problem and what we need to do to tackle it". Therapeutic Advances in Chronic Disease 3 2 (2012): 53-58. http://dx.doi.org/10.1177/2040622311430441.
    10.1177/2040622311430441
  133. Machado, Mariana Verdelho; Ferreira, Duarte M. S.; Castro, Rui E.; Silvestre, Ana Rita; Evangelista, Teresinha; Coutinho, João; Carepa, Fátima; et al. "Liver and Muscle in Morbid Obesity: The Interplay of Fatty Liver and Insulin Resistance". PLoS ONE 7 2 (2012): e31738. http://dx.doi.org/10.1371/journal.pone.0031738.
    10.1371/journal.pone.0031738
  134. Carepa F; Cortez-Pinto H; Costa A; Coutinho J; Gonçalves S; Machado MV. "Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.". (2012): http://europepmc.org/abstract/med/22098270.
    10.1111/j.1478-3231.2011.02623.x
  135. Cortez-Pinto H; Machado MV. " Gut microbiota and nonalcoholic fatty liver disease.". (2012): http://europepmc.org/abstract/med/22700625.
  136. Alvares-da-Silva, Mario Reis; Wedemeyer, Heiner; Cortez-Pinto, Helena; Marques Souza de Oliveira, Claudia Pinto; Alvares-da-Silva MR; Cortez-Pinto H; Marques Souza de Oliveira CP; Wedemeyer H. "Hepatitis C and Metabolic Disorders: Genetics, Mechanism, and Therapies (Clinical and Experimental)". International Journal of Hepatology 2012 (2012): 1-2. http://dx.doi.org/10.1155/2012/937202.
    10.1155/2012/937202
  137. Machado, M.V.; Cortez-Pinto, H.. "Fatty liver in lean patients: Is it a different disease?". Annals of Gastroenterology 25 1 (2012): 1-2. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856872322&partnerID=MN8TOARS.
  138. Machado, M.V.; Cortez-Pinto, H.. "Gut microbiota and nonalcoholic fatty liver disease". Annals of Hepatology 11 4 (2012): 440-449. http://www.scopus.com/inward/record.url?eid=2-s2.0-84862017188&partnerID=MN8TOARS.
    10.1016/s1665-2681(19)31457-7
  139. Cortez-Pinto H; Machado MV; Oliveira AG; Machado, Mariana V.; Oliveira, António G.; Cortez-Pinto, Helena. "Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients.". Journal of Gastroenterology and Hepatology (2011): no-no. http://europepmc.org/abstract/med/21649726.
    10.1111/j.1440-1746.2011.06801.x
  140. Machado, Mariana V.; Gonçalves, Sara; Carepa, Fátima; Coutinho, João; Costa, Adília; Cortez-Pinto, Helena. "Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease". Liver International 32 2 (2011): 241-248. http://dx.doi.org/10.1111/j.1478-3231.2011.02623.x.
    10.1111/j.1478-3231.2011.02623.x
  141. Cortez-Pinto H; Machado MV. "No need for a large belly to have NASH.". (2011): http://europepmc.org/abstract/med/21281684.
    10.1016/j.jhep.2011.01.010
  142. Ferreira, D. M. S.; Castro, R. E.; Machado, M. V.; Evangelista, T.; Silvestre, A.; Costa, A.; Coutinho, J.; et al. "Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease". Diabetologia 54 7 (2011): 1788-1798. http://dx.doi.org/10.1007/s00125-011-2130-8.
    10.1007/s00125-011-2130-8
  143. Machado, Mariana Verdelho; Cortez-Pinto, Helena; Cortez-Pinto H; Machado MV. "Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?". Expert Review of Gastroenterology & Hepatology 5 2 (2011): 213-222. http://dx.doi.org/10.1586/egh.11.16.
    10.1586/egh.11.16
  144. Cortez-Pinto H; Machado MV. "The dark side of sports: using steroids may harm your liver.". (2011): http://europepmc.org/abstract/med/21281427.
    10.1111/j.1478-3231.2010.02445.x
  145. Cortez-Pinto H; Machado MV. "Osteopontin: a missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis.". (2011): http://europepmc.org/abstract/med/21274859.
    10.1002/hep.24118
  146. Pimenta, Nuno; Santa-Clara, Helena; Cortez-Pinto, Helena; Rosado, Maria da Lapa; Sardinha, Luis Bettencourt; Fernhall, Bo; Nuno Pimenta; Helena Santa-Clara; Bo Fernhall. "Body Circumferences Vs BMI as Predictors of Body Fat Content in NAFLD Patients". Medicine & Science in Sports & Exercise 43 Suppl 1 (2011): 768-769. http://journals.lww.com/acsm-msse/Fulltext/2011/05001/Body_Circumferences_Vs_BMI_as_Predictors_of_Body.2199.aspx.
    Published • 10.1249/01.MSS.0000402136.18563.28
  147. Carvalho, M.R.; Jorge, Z.; Nobre, E.; Dias, T.; Cortez-Pinto, H.; Machado, V.M.; Camolas, J.; et al. "Intra-gastric ballon in the treatment of morbid obesity,Balão intra-gástrico no tratamento da obesidade mórbida". Acta Medica Portuguesa 24 4 (2011): 489-498. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856010239&partnerID=MN8TOARS.
  148. Borges M; Cortez-Pinto H; Costa J; Gouveia M; Vaz Carneiro A; dos Santos Pinheiro L; Cortez-Pinto, Helena; et al. "The burden of disease and the cost of illness attributable to alcohol drinking--results of a national study.". Alcoholism: Clinical and Experimental Research (2010): no-no. http://europepmc.org/abstract/med/20528821.
    10.1111/j.1530-0277.2010.01229.x
  149. Bellentani S; Cortez-Pinto H; Day C; Marchesini G; Ratziu V. "A position statement on NAFLD/NASH based on the EASL 2009 special conference.". (2010): http://europepmc.org/abstract/med/20494470.
    10.1016/j.jhep.2010.04.008
  150. Cortez-Pinto H; Machado MV; Oliveira AG. "Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.". (2010): http://europepmc.org/abstract/med/20578130.
    10.1002/hep.23619
  151. Jorge, Zulmira; Carvalho, Maria Raquel; Guerra, Anabela S; Alves, Natália; De Almeida, José Mendes; Fagundes, Maria João; Cortêz-Pinto, Helena; et al. "Malnutrition in morbid obesity.". (2010): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/605.
    10.20344/amp.605
  152. Jorge, Z.; Carvalho, M.R.; Guerra, A.S.; Alves, N.; De Almeida, J.M.; Fagundes, M.J.; Cortêz-Pinto, H.; Do Carmo, I.. "Malnutrition in morbid obesity,Desnutrição na obesidade mórbida". Acta Medica Portuguesa 23 2 (2010): 273-276. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953450685&partnerID=MN8TOARS.
  153. Cortez-Pinto, H.; Machado, M.V.. "Is NAFLD a significant cofactor in other liver diseases?". Nutritional Therapy and Metabolism 28 4 (2010): 151-160. http://www.scopus.com/inward/record.url?eid=2-s2.0-79958778204&partnerID=MN8TOARS.
  154. Telles-Correia, Diogo; Cortez-Pinto, Helena; Barbosa, António; Mega, Inês; Monteiro, Estela; Barbosa A; Cortez-Pinto H; et al. "Quality of life following liver transplantation: a comparative study between Familial Amyloid Neuropathy and liver disease patients". BMC Gastroenterology 9 1 (2009): http://dx.doi.org/10.1186/1471-230x-9-54.
    10.1186/1471-230x-9-54
  155. Cortez-Pinto H; Machado MV. "Uncoupling proteins and non-alcoholic fatty liver disease.". (2009): http://europepmc.org/abstract/med/19328582.
    10.1016/j.jhep.2009.02.019
  156. Cortez-Pinto, Helena; Machado, Mariana V.. "Uncoupling proteins and non-alcoholic fatty liver disease". Journal of Hepatology 50 5 (2009): 857-860. http://dx.doi.org/10.1016/j.jhep.2009.02.019.
    10.1016/j.jhep.2009.02.019
  157. Almeida R; Camilo ME; Cortez-Pinto H; Gonçalves MS; Machado MV; Marques-Vidal P; Martins A. "Does the simultaneous tumor necrosis factor receptor 2, tumor necrosis factor promoter gene polymorphism represent a higher risk for alcoholic liver disease?". (2009): http://europepmc.org/abstract/med/19212208.
    10.1097/MEG.0b013e32831016e0
  158. Almeida MR; Camilo ME; Cortez-Pinto H; Machado MV; Martins A; Ravasco P. "Iron homeostasis and H63D mutations in alcoholics with and without liver disease.". (2009): http://europepmc.org/abstract/med/19115475.
    10.3748/wjg.15.106
  159. Cortez-Pinto H; Machado MV; Machado, M.V.; Cortez-Pinto, H.. "Insulin resistance and steatosis in chronic hepatitis C.". Annals of Hepatology 8 SUPPL. 1 (2009): http://europepmc.org/abstract/med/19381127.
    10.1016/s1665-2681(19)31829-0
  160. Cortez-Pinto H; Machado M. "Are genes really important in alcoholic liver disease?". (2008): http://europepmc.org/abstract/med/18989150.
    10.1097/MEG.0b013e328304b6dd
  161. Aranha MM; Camilo ME; Cortez-Pinto H; Costa A; Rodrigues CM; da Silva IB; de Moura MC. "Bile acid levels are increased in the liver of patients with steatohepatitis.". (2008): http://europepmc.org/abstract/med/18467911.
    10.1097/MEG.0b013e3282f4710a
  162. Cortez-Pinto H; Machado M. "Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.". (2008): http://europepmc.org/abstract/med/19072357.
    10.1586/17474124.2.2.217
  163. Cortez-Pinto, Helena; Machado, Mariana. "Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease". Expert Review of Gastroenterology & Hepatology 2 2 (2008): 217-231. http://dx.doi.org/10.1586/17474124.2.2.217.
    10.1586/17474124.2.2.217
  164. Cortez-Pinto H; Machado M. "Previous practice of high-intensity sports as a risk factor for non-alcoholic steatohepatitis.". (2008): http://europepmc.org/abstract/med/18290780.
    10.1111/j.1478-3231.2008.01663.x
  165. Baldeiras I; Camilo ME; Cortez-Pinto H; Jesus L; Machado MV; Marques-Vidal P; Oliveira CR; Proença T; Ravasco P. "Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet.". (2008): http://europepmc.org/abstract/med/18938777.
    10.1080/00365520701559003
  166. Cortez-Pinto H; Machado M. "Nash, insulin resistance and iron.". (2006): http://europepmc.org/abstract/med/17105580.
    10.1111/j.1478-3231.2006.01394.x
  167. Cortez-Pinto, H.; Jesus, L.; Barros, H.; Lopes, C.; Moura, M.C.; Camilo, M.E.. "How different is the dietary pattern in non-alcoholic steatohepatitis patients?". Clinical Nutrition 25 5 (2006): 816-823. http://dx.doi.org/10.1016/j.clnu.2006.01.027.
    10.1016/j.clnu.2006.01.027
  168. Cortez-Pinto H; Machado M; Marques-Vidal P. "Hepatic histology in obese patients undergoing bariatric surgery.". (2006): http://europepmc.org/abstract/med/16899321.
    10.1016/j.jhep.2006.06.013
  169. Cortez-Pinto H; Machado M. "Non-alcoholic steatohepatitis and metabolic syndrome.". (2006): http://europepmc.org/abstract/med/16912563.
    10.1097/01.mco.0000241677.40170.17
  170. Camilo ME; Castro RE; Cortez-Pinto H; Costa A; Moura MC; Ramalho RM; Rodrigues CM; Solá S. "Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis.". (2006): http://europepmc.org/abstract/med/16357615.
    10.1097/00042737-200601000-00005
  171. Cortez-Pinto, Helena; de Moura, Miguel Carneiro; Day, Christopher Paul; Cortez-Pinto H; Day CP; de Moura MC. "Non-alcoholic steatohepatitis: From cell biology to clinical practice". Journal of Hepatology 44 1 (2006): 197-208. http://dx.doi.org/10.1016/j.jhep.2005.09.002.
    10.1016/j.jhep.2005.09.002
  172. Martins, A.S.M.; Cortez-Pinto, H.; Marques-Vidal, P.; Mendes, N.; Silva, S.; Fatela, N.; Glória, H.; et al. "Treatment and prognostic factors in patients with hepatocellular carcinoma". Liver International 26 6 (2006): 680-687. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745684425&partnerID=MN8TOARS.
    10.1111/j.1478-3231.2006.001285.x
  173. CORTEZ-PINTO, H.. "Concluding remarks: metabolic syndrome, liver and HCV". Alimentary Pharmacology and Therapeutics 22 s2 (2005): 83-85. http://dx.doi.org/10.1111/j.1365-2036.2005.02604.x.
    10.1111/j.1365-2036.2005.02604.x
  174. Camilo ME; Cortez-Pinto H; Gonçalves MS; Machado M; Marques-Vidal P; Martins A; Soren S; de Moura MC. "Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease?". (2005): http://europepmc.org/abstract/med/16148556.
    10.1097/00042737-200510000-00014
  175. Cortez-Pinto, Helena; Ermelinda Camilo, Maria; Camilo ME; Cortez-Pinto H. "Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course". Best Practice & Research Clinical Gastroenterology 18 6 (2004): 1089-1104. http://dx.doi.org/10.1016/j.bpg.2004.06.021.
    10.1016/j.bpg.2004.06.021
  176. Baptista A; Camilo ME; Castro RE; Cortez-Pinto H; Moura MC; Ramalho RM; Ribeiro PS; Rodrigues CM; Solá S. "Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.". (2004): http://europepmc.org/abstract/med/15330907.
    10.1111/j.1572-0241.2004.40009.x
  177. Cortez-Pinto H; Marques-Vidal P; Monteiro E. "Liver disease-related admissions in Portugal: clinical and demographic pattern.". (2004): http://europepmc.org/abstract/med/15316411.
    10.1097/00042737-200409000-00010
  178. Baptista A; Camilo ME; Cortez-Pinto H; De Moura MC. "Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients.". (2003): http://europepmc.org/abstract/med/14627331.
    10.1023/A:1026152415917
  179. Neuschwander-Tetri; Caldwell; Angulo, P.; Cortez-Pinto, H.; McCullough, A.J.. "Erratum: Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference (Hepatology (2003) 37 (1202-1219))". Hepatology 38 2 (2003): 536-536. http://www.scopus.com/inward/record.url?eid=2-s2.0-0043267995&partnerID=MN8TOARS.
    10.1002/hep.510380242
  180. Alexandrino P; Alves MM; Camilo ME; Cortez-Pinto H; Gouveia-Oliveira A; Moura MC; Santos PM. "Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial.". (2002): http://europepmc.org/abstract/med/11943949.
    10.1097/00042737-200204000-00007
  181. Cortez-Pinto, H.; Pinto Correia, A.; Camilo, M.E.; Tavares, L.; Carneiro De Moura, M.. "Long-term management of percutaneous endoscopic gastrostomy by a nutritional support team". Clinical Nutrition 21 1 (2002): 27-31. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036210184&partnerID=MN8TOARS.
    10.1054/clnu.2001.0499
  182. Dinis-Ribeiro, M.; Cortez-Pinto, H.; Marinho, R.; Valente, A.; Raimundo, M.; Salgado, Ma.J.; Ramalho, F.; Alexandrino, P.; Carneiro-de-Moura, M.. "Spontaneous bacterial peritonitis in patients with hepatic cirrhosis: Evaluation of a treatment protocol at specialized units". Revista Espanola de Enfermedades Digestivas 94 8 (2002): 478-481. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036675475&partnerID=MN8TOARS.
  183. Tavares De Almeida, I.; Cortez-Pinto, H.; Fidalgo, G.; Rodrigues, D.; Camilo, M.E.. "Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis". Clinical Nutrition 21 3 (2002): 219-223. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036330904&partnerID=MN8TOARS.
    10.1054/clnu.2001.0529
  184. Cortez-Pinto, H.; Baptista, A.; Camilo, M.E.; De Moura, M.C.. "Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis". Hepato-Gastroenterology 48 37 (2001): 87-90. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035102486&partnerID=MN8TOARS.
  185. Cortez-Pinto, H.; Ferra, M.A.; Baptista, A.; De Moura, M.C.; Portela-Gomes, G.M.. "Serum gastrin and gastrin-immunoreactive cells in the antral mucosa of patients with alcoholic liver disease". APMIS 108 1 (2000): 51-56. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033950191&partnerID=MN8TOARS.
    10.1034/j.1600-0463.2000.d01-5.x
  186. Ramalho, F.; Costa, A.; Pires, A.; Cabrita, P.; Serejo, F.; Pinto Correia, A.; Fatela, N.; et al. "Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C". Digestive Diseases and Sciences 45 1 (2000): 182-187. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034001484&partnerID=MN8TOARS.
    10.1023/A:1005442317680
  187. Cortez-Pinto, H.; Hui Zhi Lin; Shi Qi Yang; Da Costa, S.O.; Diehl, A.M.. "Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes". Gastroenterology 116 5 (1999): 1184-1193. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032959236&partnerID=MN8TOARS.
    10.1016/S0016-5085(99)70022-3
  188. Cortez-Pinto, H.; Chatham, J.; Chacko, V.P.; Arnold, C.; Rashid, A.; Diehl, A.M.. "Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study". JAMA 282 17 (1999): 1659-1664. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033520771&partnerID=MN8TOARS.
    10.1001/jama.282.17.1659
  189. Cortez-Pinto, H.; Camilo, M.E.; Baptista, A.; De Oliveira, A.G.; De Moura, M.C.. "Non-alcoholic fatty liver: Another feature of the metabolic syndrome?". Clinical Nutrition 18 6 (1999): 353-358. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033373699&partnerID=MN8TOARS.
    10.1016/S0261-5614(99)80015-6
  190. Cortez-Pinto, H.; Qi Yang, S.; Lin, H.Z.; Costa, S.; Hwang, C.-S.; Lane, M.D.; Bagby, G.; Diehl, A.M.. "Bacterial lipopolysaccharide induces uncoupling protein-2 expression in hepatocytes by a tumor necrosis factor-a-dependent mechanism". Biochemical and Biophysical Research Communications 251 1 (1998): 313-319. http://www.scopus.com/inward/record.url?eid=2-s2.0-0344624846&partnerID=MN8TOARS.
    10.1006/bbrc.1998.9473
  191. Goncalves, R.; Cortez Pinto, H.; Serejo, F.; Ramalho, F.. "2. Adult Scholein-Henoch purpura after enalapril [2]". Journal of Internal Medicine 244 4 (1998): 356-357. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032184777&partnerID=MN8TOARS.
    10.1046/j.1365-2796.1998.00405.x
  192. Fidalgo, P.; Matos, L.; Simoes, I.; Cortez Pinto, H.; Pinto Correia, J.. "Current therapy of ascites,ASCITE: NOVAS TERAPEUTICAS". Jornal das Ciencias Medicas 155 4 (1991): 211-217. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026318242&partnerID=MN8TOARS.
Thesis / Dissertation
  1. Reis, Ana Catarina Ferrão. "A importância dos cuidados paliativos na doença hepática terminal". Master, 2021. http://hdl.handle.net/10451/51262.
  2. Henriques, Ana Carolina Freitas. "Colangite biliar primária : tratamento clássico e novas perspetivas". Master, 2018. http://hdl.handle.net/10451/41756.
  3. Serrano, Sílvia Isabel Serrasqueiro. "Esteato-hepatite não alcoólica (EHNA) : métodos não invasivos". Master, 2017. http://hdl.handle.net/10451/33504.
  4. Costa, Catarina Borges, 1989-. "Evolução do padrão alimentar a longo prazo após cirurgia bariátrica". Master, 2017. http://hdl.handle.net/10451/39308.
  5. Moutinho, Ana Carlota Feu Dias Ferreira. "Tuberculose peritoneal : um desafio diagnóstico". Master, 2016. http://hdl.handle.net/10451/25870.
  6. Aguiar, Maria Margarida Branco Antunes Baptista Queiroz; Aguiar, Maria Margarida Branco Antunes Baptista Queiroz, 1964-. "Nutrição parentérica em meio hospitalar: prescrição, produção e acompanhamento clínico (estudo observacional sobre o impacto do IMC e da ingestão calórica-proteica no resultado clínico)". Master, 2016. http://hdl.handle.net/10400.21/11425.
  7. Lopes, Mariana Martins Conceição da Silva, 1992. "Padrão nutricional de doentes cirróticos e de doentes com carcinoma hepatocelular". Master, 2016. http://hdl.handle.net/10451/32876.
  8. Boieiro, Inês Mónica, 1991-. "Estágio no Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais : avaliação do estado nutricional e da capacidade funcional de doentes com diagnóstico clínico de AVC". Master, 2016. http://hdl.handle.net/10451/33349.
  9. Figueiredo, Patrícia Filipa Conde, 1992-. "Doença aguda do enxerto-versus-hospedeiro : a propósito de um caso clínico". Master, 2016. http://hdl.handle.net/10451/29332.
  10. Almeida, Leonor de Faro Viana Pereira de, 1988-. "Relatório de estágio em nutrição clínica : observação e atuação no apoio nutricional em diversos serviços hospitalares". Master, 2016. http://hdl.handle.net/10451/27284.
  11. Marques, Fernando Humberto Fernandes. "Tuberculose peritoneal em doente VIH positivo : caso clínico". Master, 2015. http://hdl.handle.net/10451/25273.
  12. Penedo, Cláudia Sofia Gastão, 1990-. "Estado nutricional dos doentes oncológicos seguidos numa consulta de dietética e nutrição : relatório de estágio efetuado no Serviço de Dietética e Nutrição do Hospital de Santa Maria, EPE, Centro Hospitalar Lisboa Norte". Master, 2015. http://hdl.handle.net/10451/23312.
  13. Coelho, Ana Raquel Mano, 1989-. "Relatório de estágio de nutrição em hematologia". Master, 2015. http://hdl.handle.net/10451/24043.
  14. Queirós, Ana Clara do Vale, 1991-. "Estágio no Serviço de Dietética e Nutrição e no Departamento de Neurologia no Hospital de Santa Maria, Centro Hospitalar Lisboa Norte". Master, 2015. http://hdl.handle.net/10451/23505.
  15. Bandeira, Adriana. "Eixo intestino fígado na doença hepática alcoólica : artigo de revisão". Master, 2015. http://hdl.handle.net/10451/24741.
  16. Penedo, Cláudia Sofia Gastão. "Estado nutricional dos doentes oncológicos seguidos numa consulta de dietética e nutrição". Master, 2015. http://hdl.handle.net/10400.21/13407.
  17. Duarte, Ana Luisa Marques. "Nutrição na fisiopatologia e tratamento do fígado gordo não-alcoólico". Master, 2014. http://hdl.handle.net/10451/23829.
  18. Silvestre, MP. "Regulatory interactions between the metabolic sensors SIRT1 and AMPK in modulating PPARa linked functions, in obesity-dependent type 2 diabetes mellitus". PhD, 2014. http://hdl.handle.net/10451/12209.
  19. Magalhães, Nuno Manuel Queiroz Pimenta de. "Body composition in non-alcoholic fatty liver disease patients". PhD, 2014. http://hdl.handle.net/10400.5/7450.
  20. Gago, Miguel Franco Morgadinho. "Fígado gordo não-alcoólico : uma entidade emergente com potencial oncogénico". Master, 2014. http://hdl.handle.net/10451/24409.
  21. Ribeiro, Liliana Neves, 1989-. "Determinantes do padrão dietético no risco de desenvolver esteatose hepática, na população portuguesa". Master, 2014. http://hdl.handle.net/10451/23492.

Other

Other output
  1. Tempo de reflexão. 2014. Cortez-Pinto,Helena. http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-81782014000300001.
  2. Permeabilidade intestinal em doentes com cirrose hepática: correlação com endotoxinémia e níveis circulantes de TNF a, IL-1, E IL-6. 2011. Mão de Ferro,Susana; Salazar,Maria; Machado,Mariana; Ramalho,Fernando; Cortez Pinto,Helena; Ferro,Susana Mão de; Pinto,Helena Cortez. http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-81782011000300013.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2021/11/19 Treatment of Wilson's disease patients Gastroweekend
2021/10/06 Impact of gender in liver disease UEG Week
United European Gastroenterology (Vienna, Austria)
2021/10/06 NASH: Novel Insights in pathophysiology UEG Week
United European Gastroenterology (Vienna, Austria)
2021/09/16 NAFLD: a public health threat? NAFLD EASL Summit
Home of Hepatology (Geneva, Switzerland)
2021/07/30 Tratamento da MASH Hepatologia do Mile´nio 2021 virtual
2021/07/30 Cirurgia bariátrica e NASH Hepatologia do Mile´nio 2021 virtual
2021/07/13 Tratamento atual da DHGNA - modificação do estilo de vida é suficiente XXX SEMANA DE FÍGADO DO RIO DE JANEIRO
2021/06/23 ole of bariatric surgery in NASH Postgraduate-course The international liver congress (EASL)
Home of Hepatology
2021/06/23 Unmasking NASH: the hepatic face of metabolic dysregulation. Overview and moderation The international liver congress (EASL)
Home of Hepatology
2021/06/16 Metabolic associated fatty liver disease (MAFLD) Final Conference Meeting
Project FOIE GRAS
2021/06/12 NAFLD: what the clinician needs to know Croatian Liver Week 2021
(Split, Croatia)
2021/05/29 Obesity and NAFLD World Digestive Health Day
The World Gastroenterology Organisation
2021/05/28 Metabolic associated fatty liver disease (MAFLD) Congresso APEF 2021
(Portugal)
2021/05/28 INTERVENÇÃO NUTRICIONAL NO FÍGADO GORDO NÃO ALCOÓLICO EM DOENTES INFETADOS PELO VIH Congresso Português de Hepatologia - 2ª Reunião Anual da APEF
Associação Portuguesa para o Estudo do Fígado (Portugal)
2021/04 Epidemiology of NAFLD The 4th Global NASH Congress
2021/03/03 New insights into NASH management International Conference on the Management of Liver Diseases
2020/11/27 Treatment of NASH Hepatologia do Milênio 2020
Associação de Gastroenterologia do Rio de Janeiro (Rio de Janeiro, Brazil)
2020/10/17 Benefícios e desvantagens da nomenclatura MAFLD XXIX Semana de Fígado do Rio de Janeiro 2020
A XXXI Semana de Fígado do Rio de Janeiro (Rio de Janeiro, Brazil)
2020/09/25 MANIFESTAÇÕES HEPATOBILIARES DA DII. Curso de formação em DII do GEDI
GEDII - Grupo de Estudos da Doença Inflamatória Intestinal (Porto)
2020/07/29 NASH: Treatment & New Trials Hepato Pernambuco 2020
Sociedade Brasileira de Hepatologia (Brazil)
2020/02/07 Estudos multicêntricos em Portugal. Que podemos/devemos investigar. Curso de formação da APEF
Associação Portuguesa para o Estudo do Fígado (Portugal)
2019/09/26 Implementation of public awareness and education in schools EASL NAFLD Summit
(Sevilha, Spain)
2019/09/05 Food, microbiota and nonalcoholic fatty liver disease, in Neurogastro 2019 biennal meeting of the European Society of Neurogastroenterology and Motility
2019/07/05 Food obesity and nonalcoholic fatty liver disease Spoleto Festival dei 2Mondi
2019 Global Perspectives On Nafld And Non-Alcoholic Steatohepatitis III ETN Foie Gras Summer School
2018 NAFLD/NASH – Do diagnóstico à terapêutica. XXXIII Reunião Anual NGHD
2018 Identification of NAFLD in Primary Care: Can Algorithms and Transient Elastography (TE) Predict Fibrosis? World Preclinical Congress
2018 Encefalopatia hepática – Como tratar 6º congresso SOS Hepatites
2018 Hepahealth: The burden of liver disease in Europe The international liver congress (EASL)
2018 Discussion: Why should be the EASL policy on alcohol in Europe The international liver congress (EASL)
2018 Policy recommendation arising out of HEPAHEALTH and next steps. The international liver congress (EASL)
2018 O que vai mudar? Novas guidelines da CBP Semana Digestiva
2018 Atualidade na abordagem da hepatite alcoólica aguda VII Simpósio de Hepatites Virais de Minas Gerais
2018 The changing priorities in chronic liver disease Clinics and Science in Hepatology

Supervision

Thesis Title
Role
Degree Subject (Type)
Institution / Organization
2021 - 2021 "Impacto da sarcopénia na gravidade da cirrose hepática e do carcinoma hepatocelular"
Supervisor
Nutrição Clínica (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
2018 - 2018 Non-alcoholic liver disease in HIV infected patients: prevalence, nutritional status and dietary habits
Supervisor
Ciências e Tecnologias da Saúde (PhD)
Universidade de Lisboa Faculdade de Medicina, Portugal
2018 - 2018 Colangite Biliar Primária: Tratamento Clássico e Novas Perspetivas
Supervisor
Medicina (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
2017 - 2017 Esteato-hepatite não alcoólica - Métodos não invasivos.
Supervisor
Medicina (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal

Jury of academic degree

Topic
Role
Candidate name (Type of degree)
Institution / Organization
2022/03/22 Desenvolvimento de um modelo experimental de doença hepática alcoólica em ratos Wistar: da lesão hepática à disbiose intestinal
(Thesis) Arguer
Rutiane Ullmann Thoen (PhD)
Universidade Federal do Rio Grande do Sul, Brazil

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2022/03 - 2022/07 Patologia II Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2021/09 - 2022/02 Patologia I Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2021/09 - 2022/02 Nutrição Artificial Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2021/03 - 2021/07 Patologia II Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2020/09 - 2021/02 Patologia I Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2020/02 - 2020/07 Patologia II Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2019/09 - 2020/02 Patologia I Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
Distinctions

Award

2020 Melhor Poster no Congresso Português de Hepatologia 2020
Associação Portuguesa para o Estudo do Fígado , Portugal
2003 Rising Star in Gastroenterology 2003 - Association of National European and Mediterranean Societies of Gastroenterology

Title

2023 Mulher na Ciência
Ciência Viva, Portugal
2021 Presidente da United European Gastroenterology (UEG)
United European Gastroenterology, Austria
2019 Vice-presidente da United European Gastroenterology (UEG)
2016 Diretora do Internato Médico do Centro Hospitalar Lisboa Norte /HSM
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2015 membro do “Governing Board” da European Association for the Study of the Liver (EASL), como conselheira para os assuntos da União Europeia (UE)
2015 Membro da “Public Affair Committee (PAC) da UEG
2013 Presidente da Associação para o estudo do Fígado (APEF)
Associação Portuguesa para o Estudo do Fígado , Portugal
2008 Fellow in Gastroenterology” pelo European Board of Gastroenterology